Enhance MD Tirzepatide Review: Cost, Tiers & Honest Verdict (2026)

Enhance MD is a compounded-only telehealth program with an unusually transparent, published price ladder — standard tirzepatide, a cheaper microdose tier, and a semaglutide-plus-tirzepatide combination — with provider care and 6-month lab testing included. This review covers what Enhance MD is, what it dispenses, the compounded-versus-brand distinction, its real tiered pricing, and the catches. We disclose an affiliate relationship with Enhance MD; it never changes our scoring, and every fact here comes from Enhance MD's own program.

What Enhance MD is

Enhance MD is a compounded-only telehealth weight program built around a clearly published price ladder. A provider reviews an online intake and, where appropriate, prescribes from a tiered menu: standard compounded tirzepatide at $280/month, a lower $169/month microdose tirzepatide tier, a semaglutide-plus-tirzepatide combination at $322/month, and compounded semaglutide at $212/month ($112 the first month). Pricing is dose-flat within each tier — no surcharge as you titrate up inside a tier — and provider care and 6-month lab testing are included. NAD+ is offered as an adjacent longevity option.

The compounded-vs-brand question

Two very different products share the name tirzepatide:

• •Brand tirzepatide is Eli Lilly's FDA-approved Zepbound (weight management, obstructive sleep apnea) and Mounjaro (type 2 diabetes) — the exact molecule and dose studied in the pivotal trials.
• •Compounded tirzepatide is pharmacy-made, not FDA-approved, and was not the product tested in those trials.

Enhance MD is compounded only — there is no FDA-approved brand or oral tirzepatide pathway. That distinction matters more in 2026: the FDA declared the tirzepatide shortage resolved in October 2024, and the enforcement discretion that permitted routine large-scale compounding ended in early 2025 (around February 18, 2025 for 503A pharmacies, March 19, 2025 for 503B outsourcing facilities) — the full timeline is in our guide to whether compounded tirzepatide is still legal in 2026.

What Enhance MD costs in 2026

Enhance MD's transparency is its strongest selling point: the tiers are published openly rather than hidden behind a quiz, and each tier is dose-flat, so your bill does not climb as you titrate within it. The ladder runs $280/month for standard tirzepatide, $169/month for microdose tirzepatide, $322/month for the sema+tirz combination, and $212/month for compounded semaglutide ($112 the first month). Provider care and 6-month lab testing are bundled in. The honest counterpoint is that the standard tirzepatide tier at $280/month is higher than several rivals for the same molecule — CoreAge Rx, for example, is a flat $149.

For context on the brand drug, LillyDirect sells brand Zepbound self-pay vials at roughly $299–$449/month depending on dose (prices effective February 23, 2026; 28-day supply). For the full cash-price picture, see our Zepbound cost and savings guide.

How the care model holds up

Enhance MD's strengths are transparent, tiered pricing (including a microdose option and a sema+tirz combination), dose-flat pricing within each tier, and included provider care plus 6-month lab testing — labs are a genuine plus for safety monitoring that many compounders skip. The trade-offs: it is compounded only (no brand or oral pathway); the standard $280/month tier costs more than several rivals for the same molecule; and the states served are not published on the site, so confirm availability in your state before subscribing. Tirzepatide carries labeled warnings for acute pancreatitis, gallbladder disease, and a boxed thyroid C-cell tumor warning — see our guides on Zepbound side effects, the gallbladder risk, and the thyroid cancer warning.

Does the drug work? (Separate from the provider)

Separate the provider from the medication, and the brand molecule from a compounded copy. Brand tirzepatide's efficacy is trial-grade: in the 72-week SURMOUNT-1 trial, adults without diabetes lost on average roughly 15% to 21% of body weight across the 5–15 mg doses, versus about 3% on placebo¹; against semaglutide in SURMOUNT-5, tirzepatide produced significantly greater weight loss — about 20% versus 14%². Those results were established with the brand molecule; compounded versions were never tested in those trials, and a microdose tier uses lower-than-standard doses, so neither should be assumed to match full-dose trial results. The full picture is in our tirzepatide evidence guide.

The honest verdict

Enhance MD is a good fit if you value transparent, published tiered pricing with included labs and want options like a microdose tier or a sema+tirz combination — and you are comfortable with a compounded, non-FDA-approved product. The reservations are that the standard $280/month tier is pricier than several rivals (CoreAge Rx is a flat $149 with included support), it is compounded-only, and the states served are not listed. If lowest price with included support is your priority, weigh CoreAge; if you specifically want brand tirzepatide, price it against LillyDirect. See our best tirzepatide providers ranking and best place to get Zepbound online roundup.